Cite

HARVARD Citation

    Tiraboschi, C. et al. (2020). Combining inhibition of galectin-3 with and before a therapeutic vaccination is critical for the prostate-tumor-free outcome. Journal for immunotherapy of cancer. 8 (2), p. . [Online]. 
  
Back to record